• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Softgel Capsule Market

    ID: MRFR/Pharma/47923-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type) and By Application (Vitamins, Supplement, Nutrition)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Softgel Capsule Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    UK Softgel Capsule Market Summary

    The United Kingdom UK Softgel Capsule market is poised for substantial growth, projected to reach 1000 USD Million by 2035.

    Key Market Trends & Highlights

    UK Softgel Capsule Key Trends and Highlights

    • The market valuation for UK Softgel Capsules is estimated at 500 USD Million in 2024.
    • A compound annual growth rate (CAGR) of 6.5 percent is anticipated from 2025 to 2035.
    • By 2035, the market is expected to double in size, reaching 1000 USD Million.
    • Growing adoption of softgel capsules due to their convenience and ease of swallowing is a major market driver.

    Market Size & Forecast

    2024 Market Size 500 (USD Million)
    2035 Market Size 1000 (USD Million)
    CAGR (2025-2035) 6.5%

    Major Players

    Forte Pharma, Lonza, Eligo Bioscience, BASF, Aesculap, Aenova, Integrity Nutraceuticals, Catalent, Qualipac, Rottapharm Madaus, Capsugel, Amgen, Haleon, Stada Arzneimittel, Pharmalink

    UK Softgel Capsule Market Trends

    The UK Softgel Capsule Market is experiencing significant trends that are being driven by the increasing demand for dietary supplements and the growing health consciousness of consumers. Softgel capsules have gained popularity as a convenient and easy-to-consume form of nutritional supplementation as a result of the transition to preventive healthcare. This trend is significantly influenced by the aging population and the increase in chronic diseases in the United Kingdom, which necessitates the development of efficient delivery systems for vitamins and other health products. The UK market offers opportunities due to the increasing popularity of plant-based diets and veganism.

    In response to the growing number of environmentally conscious and health-conscious consumers, manufacturers have initiated the development of plant-based softgel capsules. This provides an opportunity for innovation and growth, particularly for companies that are prepared to invest in new technologies that can produce vegetarian and vegan softgels that can appeal to a broader customer base in the UK.. In recent years, consumers in the United Kingdom have also demonstrated a preference for transparency and quality in their health products, which has resulted in a trend toward the use of high-quality ingredients and plain labeling.

    Furthermore, the health sector's incorporation of technology has facilitated the selection of personalized supplements, allowing consumers to select softgel capsules that are specifically designed to meet their unique health needs. The landscape is changing as the government supports innovation in the healthcare sector and promotes public health initiatives, providing potential growth opportunities for businesses in the UK softgel capsule market.

    UK Softgel

    UK Softgel Capsule Market Drivers

    Market Segment Insights

    UK Softgel Capsule Market Segment Insights

    UK Softgel Capsule Market Segment Insights

    Softgel Capsule Market Type Insights

    Softgel Capsule Market Type Insights

    The UK Softgel Capsule Market is categorized into various types, notably Gelatin Type and Non-Animal Type, representing a pivotal aspect of the market segmentation. Gelatin Type softgel capsules are widely utilized due to their excellent encapsulation qualities and bioavailability, making them a preferred choice for many pharmaceutical and dietary supplement formulations. This segment has historically garnered a significant portion of the market share, attributed to the reliability and effectiveness of gelatin as a natural product.

    On the other hand, the Non-Animal Type segment, which includes plant-based and vegetarian alternatives, is rapidly gaining traction, particularly in the UK, where there’s an increasing consumer demand for vegan and vegetarian options. The rise of health consciousness among UK consumers has catalyzed the growth of this segment, presenting an opportunity for manufacturers to innovate in plant-derived materials while meeting dietary needs and ethical considerations. The growing concerns for animal welfare and the environment have also bolstered the demand for Non-Animal Type softgel capsules, reflecting a notable shift in consumer preferences.

    Additionally, as awareness regarding dietary supplements increases, many manufacturers are adapting their product lines to include non-animal softgel options in response to this evolving landscape. Each type of softgel plays a crucial role in ensuring that consumers have access to effective and preferable dosage forms that align with their individual dietary needs and values. The UK government’s initiatives promoting healthier lifestyles and dietary supplements further enhance the prospects for both types, fostering a competitive environment in the industry.

    As innovation continues, the segmentation within the UK Softgel Capsule Market will likely evolve, catering to diverse consumer preferences while addressing market growth dynamics and emerging trends. Each type, therefore, is not just a product offering but significant to overall market strategies and consumer satisfaction, affecting industry standards and projections alike.

    Softgel Capsule Market Application Insights

    Softgel Capsule Market Application Insights

    The Application segment of the UK Softgel Capsule Market plays a crucial role in catering to diverse consumer needs, focusing primarily on Vitamins, Supplements, and Nutrition. This segment reflects a significant trend towards preventive healthcare and wellness, as consumers increasingly favor dietary supplements that promote overall health. With changing lifestyles and rising health awareness, the demand for vitamins has grown noticeably, driven by factors such as the aging population in the UK and a greater emphasis on fitness.

    The supplement category is particularly prominent, addressing various health concerns and driving innovation in product development.Additionally, the nutrition aspect shapes the market, appealing to several demographics, including athletes and health-conscious individuals. Given the UK's established pharmaceutical regulations, consumers often seek quality products that are effective and safe, further enhancing the significance of this Application segment. As health trends evolve, opportunities arise for manufacturers to introduce innovative softgel formulations that cater to specific health needs, ensuring sustained market growth and adaptation to consumer preferences.

    Get more detailed insights about UK Softgel Capsule Market Research Report-Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The UK Softgel Capsule Market has seen significant growth and competition driven by an increasing demand for dietary supplements and pharmaceuticals that offer enhanced bioavailability and convenience. Motivated by consumer preferences for easy-to-swallow formats, manufacturers are innovating to develop softgel products that cater to various health and wellness needs. The competition is characterized by a mix of established pharmaceutical companies and specialized nutraceutical firms, all vying for market share through product differentiation, branding, and strategic partnerships.

    In this landscape, companies seek to leverage their research and development capabilities to introduce new formulations and expand their product lines to meet diverse consumer demands while adhering to regulatory standards. Forte Pharma has established a strong foothold in the UK Softgel Capsule Market by focusing on wellness products that align with consumer trends toward health enhancement and natural solutions. The brand is recognized for its commitment to developing high-quality, effective dietary supplements, particularly those aimed at solving specific health issues such as weight management, energy boosting, and skin health.

    Forte Pharma's strengths in the UK market can be attributed to its well-defined product portfolio, strong brand loyalty among consumers, and dedicated distribution channels that facilitate accessibility. The company's marketing strategies emphasize transparency and efficacy, helping to build trust and a solid reputation in a competitive landscape where consumers are increasingly discerning about the supplements they choose.Lonza is a prominent player in the UK Softgel Capsule Market, leveraging its extensive expertise in the life sciences sector to deliver high-quality softgel solutions for dietary supplements and pharmaceuticals.

    Known for its robust manufacturing capabilities, Lonza's portfolio includes a range of softgel formulations that cater to various applications, ensuring compliance with stringent regulatory requirements. The company is committed to innovation, investing in research and development to enhance its product offerings continuously. Lonza's strength lies in its ability to customize formulations according to specific customer needs, providing tailored solutions that support its clients' market strategies. The presence of Lonza in the UK market is further reinforced by strategic mergers and partnerships, allowing for greater operational efficiencies and access to a wider customer base.

    Their dedication to sustainability and quality assurance also distinguishes them in the marketplace, enabling them to meet the rising consumer expectations for clean-label products.

    Key Companies in the UK Softgel Capsule Market market include

    Industry Developments

    The UK Softgel Capsule Market has witnessed significant developments recently, with companies like Lonza and Capsugel actively enhancing their manufacturing capabilities. In March 2023, Aenova expanded its operations with a new facility aimed at improving production efficiency and meeting rising consumer demand. The market is also experiencing growth in valuation, driven by the increasing popularity of dietary supplements, with Forte Pharma and Integrity Nutraceuticals leading in innovation. Mergers and acquisitions have played a crucial role.

    Notably, in June 2023, Amgen announced a strategic acquisition that aims to strengthen its market position in the biopharmaceutical sector, while Stada Arzneimittel expanded its product lineup. The DNA-based therapies sector is also tangentially linked, with Eligo Bioscience exploring partnerships to enhance delivery systems in softgel formulations. Additionally, ongoing research and development advances are set to influence growth as companies adapt to consumer trends and regulatory changes, reflecting an increasing emphasis on sustainable practices within the industry.

    Major happenings over the past 2-3 years include the push for transparency in ingredient sourcing and the regulatory scrutiny of softgel formulations, with the UK government advocating for stricter quality standards to ensure consumer safety.

    Market Segmentation

    Outlook

    • Vitamins
    • Supplement
    • Nutrition

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 468.75(USD Million)
    MARKET SIZE 2024 500.0(USD Million)
    MARKET SIZE 2035 1000.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.504% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Forte Pharma, Lonza, Eligo Bioscience, BASF, Aesculap, Aenova, Integrity Nutraceuticals, Catalent, Qualipac, Rottapharm Madaus, Capsugel, Amgen, Haleon, Stada Arzneimittel, Pharmalink
    SEGMENTS COVERED Type, Application
    KEY MARKET OPPORTUNITIES Rising demand for nutraceuticals, Increasing preference for convenience products, Growth in aging population, Expanding herbal supplement market, Innovations in capsule technology
    KEY MARKET DYNAMICS rising health consciousness, increasing demand for dietary supplements, technological advancements in manufacturing, growing prevalence of chronic diseases, preference for convenient dosage forms
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the UK Softgel Capsule Market in 2024?

    The UK Softgel Capsule Market is expected to be valued at 500.0 USD Million in 2024.

    What will the market size be in 2035?

    By 2035, the UK Softgel Capsule Market is expected to reach a valuation of 1000.0 USD Million.

    What is the expected CAGR for the UK Softgel Capsule Market from 2025 to 2035?

    The expected CAGR for the UK Softgel Capsule Market from 2025 to 2035 is 6.504%.

    What are the expected market values for Gelatin Type Softgel Capsules in 2024 and 2035?

    The Gelatin Type Softgel Capsules are valued at 300.0 USD Million in 2024 and expected to reach 600.0 USD Million by 2035.

    What are the expected market values for Non-Animal Type Softgel Capsules in 2024 and 2035?

    The Non-Animal Type Softgel Capsules are expected to be valued at 200.0 USD Million in 2024 and 400.0 USD Million in 2035.

    Who are the major players in the UK Softgel Capsule Market?

    Key players in the UK Softgel Capsule Market include Forte Pharma, Lonza, Eligo Bioscience, BASF, Aesculap, Aenova, Integrity Nutraceuticals, Catalent, and others.

    What is the expected growth rate of the UK Softgel Capsule Market?

    The UK Softgel Capsule Market is anticipated to grow at a rate of 6.504% from 2025 to 2035.

    What are the key applications driving the growth of the UK Softgel Capsule Market?

    Key applications driving the growth of the UK Softgel Capsule Market include nutraceuticals, pharmaceuticals, and dietary supplements.

    What emerging trends are influencing the UK Softgel Capsule Market?

    Emerging trends include the increasing demand for plant-based softgel options and innovative delivery methods.

    What challenges does the UK Softgel Capsule Market face?

    Challenges in the UK Softgel Capsule Market include regulatory hurdles and competition from alternative delivery formats.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK Softgel Capsule Market, BY Type (USD Million)
    45. Gelatin Type
    46. Non-Animal Type
    47. UK Softgel Capsule Market, BY Application (USD Million)
    48. Vitamins
    49. Supplement
    50. Nutrition
    51. Competitive Landscape
    52. Overview
    53. Competitive Analysis
    54. Market share Analysis
    55. Major Growth Strategy in the Softgel Capsule Market
    56. Competitive Benchmarking
    57. Leading Players in Terms of Number of Developments in the Softgel Capsule Market
    58. Key developments and growth strategies
    59. New Product Launch/Service Deployment
    60. Merger & Acquisitions
    61. Joint Ventures
    62. Major Players Financial Matrix
    63. Sales and Operating Income
    64. Major Players R&D Expenditure. 2023
    65. Company Profiles
    66. Forte Pharma
    67. Financial Overview
    68. Products Offered
    69. Key Developments
    70. SWOT Analysis
    71. Key Strategies
    72. Lonza
    73. Financial Overview
    74. Products Offered
    75. Key Developments
    76. SWOT Analysis
    77. Key Strategies
    78. Eligo Bioscience
    79. Financial Overview
    80. Products Offered
    81. Key Developments
    82. SWOT Analysis
    83. Key Strategies
    84. BASF
    85. Financial Overview
    86. Products Offered
    87. Key Developments
    88. SWOT Analysis
    89. Key Strategies
    90. Aesculap
    91. Financial Overview
    92. Products Offered
    93. Key Developments
    94. SWOT Analysis
    95. Key Strategies
    96. Aenova
    97. Financial Overview
    98. Products Offered
    99. Key Developments
    100. SWOT Analysis
    101. Key Strategies
    102. Integrity Nutraceuticals
    103. Financial Overview
    104. Products Offered
    105. Key Developments
    106. SWOT Analysis
    107. Key Strategies
    108. Catalent
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Qualipac
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. Rottapharm Madaus
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. Capsugel
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Amgen
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. Haleon
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Stada Arzneimittel
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. Pharmalink
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. References
    157. Related Reports
    158. UK Softgel Capsule Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    159. UK Softgel Capsule Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    160. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    161. ACQUISITION/PARTNERSHIP
    162. MARKET SYNOPSIS
    163. UK SOFTGEL CAPSULE MARKET ANALYSIS BY TYPE
    164. UK SOFTGEL CAPSULE MARKET ANALYSIS BY APPLICATION
    165. KEY BUYING CRITERIA OF SOFTGEL CAPSULE MARKET
    166. RESEARCH PROCESS OF MRFR
    167. DRO ANALYSIS OF SOFTGEL CAPSULE MARKET
    168. DRIVERS IMPACT ANALYSIS: SOFTGEL CAPSULE MARKET
    169. RESTRAINTS IMPACT ANALYSIS: SOFTGEL CAPSULE MARKET
    170. SUPPLY / VALUE CHAIN: SOFTGEL CAPSULE MARKET
    171. SOFTGEL CAPSULE MARKET, BY TYPE, 2025 (% SHARE)
    172. SOFTGEL CAPSULE MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    173. SOFTGEL CAPSULE MARKET, BY APPLICATION, 2025 (% SHARE)
    174. SOFTGEL CAPSULE MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    175. BENCHMARKING OF MAJOR COMPETITORS

    UK Softgel Capsule Market Segmentation

    • Softgel Capsule Market By Type (USD Million, 2019-2035)

      • Gelatin Type
      • Non-Animal Type

     

    • Softgel Capsule Market By Application (USD Million, 2019-2035)

      • Vitamins
      • Supplement
      • Nutrition

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials